Listed

Travere Therapeutics, Inc.

TVTXNasdaqCIK 1438533HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$169.6m, Q2 FY2026
Operating income$4.0m, Q2 FY2026
Net income−$34.8m, Q2 FY2026
Travere Therapeutics, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m37.1Revenue, Q3 FY2023, three months to 2023-09-30$37.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-10-31, accession 0001438533-24-000048.Report this figure45.1Revenue, Q4 FY2023, three months to 2023-12-31$45.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-02-20, accession 0001438533-24-000005.Report this figure41.4Revenue, Q1 FY2024, three months to 2024-03-31$41.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-01, accession 0001438533-25-000026.Report this figure54.1Revenue, Q2 FY2024, three months to 2024-06-30$54.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-06, accession 0001438533-25-000046.Report this figure62.9Revenue, Q3 FY2024, three months to 2024-09-30$62.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-30, accession 0001438533-25-000056.Report this figure74.8Revenue, Q4 FY2024, three months to 2024-12-31$74.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001438533-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure81.7Revenue, Q1 FY2025, three months to 2025-03-31$81.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-04, accession 0001438533-26-000042.Report this figure114Revenue, Q2 FY2025, three months to 2025-06-30$114.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-04, accession 0001438533-26-000063.Report this figure165Revenue, Q3 FY2025, three months to 2025-09-30$164.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-10-30, accession 0001438533-25-000056.Report this figure130Revenue, Q4 FY2025, three months to 2025-12-31$129.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-02-19, accession 0001438533-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure127Revenue, Q1 FY2026, three months to 2026-03-31$127.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-04, accession 0001438533-26-000042.Report this figure170Revenue, Q2 FY2026, three months to 2026-06-30$169.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-04, accession 0001438533-26-000063.Report this figure
Cost of revenue$m1.3Cost of revenue, Q3 FY2023, three months to 2023-09-30$1.3m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2024-10-31, accession 0001438533-24-000048.Report this figure4.6Cost of revenue, Q4 FY2023, three months to 2023-12-31$4.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-19, accession 0001438533-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure1.5Cost of revenue, Q1 FY2024, three months to 2024-03-31$1.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-05-01, accession 0001438533-25-000026.Report this figure2.1Cost of revenue, Q2 FY2024, three months to 2024-06-30$2.1m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-08-06, accession 0001438533-25-000046.Report this figure1.6Cost of revenue, Q3 FY2024, three months to 2024-09-30$1.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-10-30, accession 0001438533-25-000056.Report this figure2.6Cost of revenue, Q4 FY2024, three months to 2024-12-31$2.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-19, accession 0001438533-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure4.7Cost of revenue, Q1 FY2025, three months to 2025-03-31$4.7m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-04, accession 0001438533-26-000042.Report this figure1.5Cost of revenue, Q2 FY2025, three months to 2025-06-30$1.5m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-04, accession 0001438533-26-000063.Report this figure1.6Cost of revenue, Q3 FY2025, three months to 2025-09-30$1.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2025-10-30, accession 0001438533-25-000056.Report this figure2.6Cost of revenue, Q4 FY2025, three months to 2025-12-31$2.6m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-K filed 2026-02-19, accession 0001438533-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure2.0Cost of revenue, Q1 FY2026, three months to 2026-03-31$1.9m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-05-04, accession 0001438533-26-000042.Report this figure2.2Cost of revenue, Q2 FY2026, three months to 2026-06-30$2.2m. XBRL concept us-gaap:CostOfGoodsAndServicesSold. 10-Q filed 2026-08-04, accession 0001438533-26-000063.Report this figure
Research and development$m0.0Research and development, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2023-11-07, accession 0001438533-23-000048. Derived: 9-month figure less the 6-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Selling, general and administrative$m67.8Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$67.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-10-31, accession 0001438533-24-000048.Report this figure63.6Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$63.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-19, accession 0001438533-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure64.2Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$64.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-01, accession 0001438533-25-000026.Report this figure64.8Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$64.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-06, accession 0001438533-25-000046.Report this figure65.6Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$65.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-10-30, accession 0001438533-25-000056.Report this figure69.5Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$69.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-19, accession 0001438533-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure60.4Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$60.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-04, accession 0001438533-26-000042.Report this figure62.6Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$62.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-04, accession 0001438533-26-000063.Report this figure86.5Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$86.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-10-30, accession 0001438533-25-000056.Report this figure102Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$101.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-19, accession 0001438533-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure80.3Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$80.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-04, accession 0001438533-26-000042.Report this figure96.1Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$96.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-04, accession 0001438533-26-000063.Report this figure
Operating income$m(92.6)Operating income, Q3 FY2023, three months to 2023-09-30−$92.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-10-31, accession 0001438533-24-000048.Report this figure(94.2)Operating income, Q4 FY2023, three months to 2023-12-31−$94.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-02-20, accession 0001438533-24-000005.Report this figure(139)Operating income, Q1 FY2024, three months to 2024-03-31−$139.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-01, accession 0001438533-25-000026.Report this figure(67.7)Operating income, Q2 FY2024, three months to 2024-06-30−$67.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-06, accession 0001438533-25-000046.Report this figure(56.1)Operating income, Q3 FY2024, three months to 2024-09-30−$56.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-30, accession 0001438533-25-000056.Report this figure(60.7)Operating income, Q4 FY2024, three months to 2024-12-31−$60.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-19, accession 0001438533-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure(42.7)Operating income, Q1 FY2025, three months to 2025-03-31−$42.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-04, accession 0001438533-26-000042.Report this figure(12.7)Operating income, Q2 FY2025, three months to 2025-06-30−$12.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-04, accession 0001438533-26-000063.Report this figure24.9Operating income, Q3 FY2025, three months to 2025-09-30$24.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-10-30, accession 0001438533-25-000056.Report this figure(32.4)Operating income, Q4 FY2025, three months to 2025-12-31−$32.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-19, accession 0001438533-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure(36.9)Operating income, Q1 FY2026, three months to 2026-03-31−$36.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-04, accession 0001438533-26-000042.Report this figure4.0Operating income, Q2 FY2026, three months to 2026-06-30$4.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-04, accession 0001438533-26-000063.Report this figure
Interest expense$m2.8Interest expense, Q3 FY2023, three months to 2023-09-30$2.8m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-07, accession 0001438533-23-000048.Report this figure2.8Interest expense, Q4 FY2023, three months to 2023-12-31$2.8m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-02-20, accession 0001438533-24-000005. Derived: 12-month figure less the 9-month figure.Report this figure2.8Interest expense, Q1 FY2024, three months to 2024-03-31$2.8m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-06, accession 0001438533-24-000020.Report this figure2.8Interest expense, Q2 FY2024, three months to 2024-06-30$2.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-06, accession 0001438533-25-000046.Report this figure2.8Interest expense, Q3 FY2024, three months to 2024-09-30$2.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-10-30, accession 0001438533-25-000056.Report this figure2.8Interest expense, Q4 FY2024, three months to 2024-12-31$2.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-19, accession 0001438533-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure2.9Interest expense, Q1 FY2025, three months to 2025-03-31$2.9m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-04, accession 0001438533-26-000042.Report this figure2.8Interest expense, Q2 FY2025, three months to 2025-06-30$2.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-04, accession 0001438533-26-000063.Report this figure2.8Interest expense, Q3 FY2025, three months to 2025-09-30$2.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-10-30, accession 0001438533-25-000056.Report this figure2.3Interest expense, Q4 FY2025, three months to 2025-12-31$2.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-19, accession 0001438533-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure2.3Interest expense, Q1 FY2026, three months to 2026-03-31$2.3m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-04, accession 0001438533-26-000042.Report this figure2.1Interest expense, Q2 FY2026, three months to 2026-06-30$2.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-04, accession 0001438533-26-000063.Report this figure
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$12.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-10-31, accession 0001438533-24-000048.Report this figure0.1Income tax, Q4 FY2023, three months to 2023-12-31$68.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-19, accession 0001438533-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure0.2Income tax, Q1 FY2024, three months to 2024-03-31$191.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-01, accession 0001438533-25-000026.Report this figure0.1Income tax, Q2 FY2024, three months to 2024-06-30$85.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-06, accession 0001438533-25-000046.Report this figure(0.1)Income tax, Q3 FY2024, three months to 2024-09-30−$84.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-30, accession 0001438533-25-000056.Report this figure(0.1)Income tax, Q4 FY2024, three months to 2024-12-31−$72.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-19, accession 0001438533-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$39.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-04, accession 0001438533-26-000042.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$20.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-04, accession 0001438533-26-000063.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$8.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-10-30, accession 0001438533-25-000056.Report this figure0.9Income tax, Q4 FY2025, three months to 2025-12-31$921.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-19, accession 0001438533-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure(0.1)Income tax, Q1 FY2026, three months to 2026-03-31−$120.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-04, accession 0001438533-26-000042.Report this figure(0.2)Income tax, Q2 FY2026, three months to 2026-06-30−$204.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-04, accession 0001438533-26-000063.Report this figure
Net income$m151Net income, Q3 FY2023, three months to 2023-09-30$150.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-10-31, accession 0001438533-24-000048.Report this figure(90.2)Net income, Q4 FY2023, three months to 2023-12-31−$90.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-02-20, accession 0001438533-24-000005.Report this figure(136)Net income, Q1 FY2024, three months to 2024-03-31−$136.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-01, accession 0001438533-25-000026.Report this figure(70.4)Net income, Q2 FY2024, three months to 2024-06-30−$70.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-06, accession 0001438533-25-000046.Report this figure(54.8)Net income, Q3 FY2024, three months to 2024-09-30−$54.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001438533-25-000056.Report this figure(60.3)Net income, Q4 FY2024, three months to 2024-12-31−$60.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-19, accession 0001438533-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure(41.2)Net income, Q1 FY2025, three months to 2025-03-31−$41.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-04, accession 0001438533-26-000042.Report this figure(12.8)Net income, Q2 FY2025, three months to 2025-06-30−$12.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001438533-26-000063.Report this figure25.7Net income, Q3 FY2025, three months to 2025-09-30$25.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-10-30, accession 0001438533-25-000056.Report this figure2.7Net income, Q4 FY2025, three months to 2025-12-31$2.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-19, accession 0001438533-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure(37.1)Net income, Q1 FY2026, three months to 2026-03-31−$37.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-04, accession 0001438533-26-000042.Report this figure(34.8)Net income, Q2 FY2026, three months to 2026-06-30−$34.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001438533-26-000063.Report this figure
Diluted EPS$ per share1.97Diluted EPS, Q3 FY2023, three months to 2023-09-30$1.97 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-10-31, accession 0001438533-24-000048.Report this figure(1.18)Diluted EPS, Q4 FY2023, three months to 2023-12-31−$1.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-02-20, accession 0001438533-24-000005.Report this figure(1.76)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$1.76 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-01, accession 0001438533-25-000026.Report this figure(0.91)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.91 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-06, accession 0001438533-25-000046.Report this figure(0.70)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.70 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-30, accession 0001438533-25-000056.Report this figurenot reported(0.47)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.47 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-04, accession 0001438533-26-000042.Report this figure(0.14)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-04, accession 0001438533-26-000063.Report this figure0.28Diluted EPS, Q3 FY2025, three months to 2025-09-30$0.28 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-10-30, accession 0001438533-25-000056.Report this figurenot reported(0.40)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.40 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-04, accession 0001438533-26-000042.Report this figure(0.37)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.37 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-04, accession 0001438533-26-000063.Report this figure
Basic EPS$ per share1.97Basic EPS, Q3 FY2023, three months to 2023-09-30$1.97 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-10-31, accession 0001438533-24-000048.Report this figure(1.18)Basic EPS, Q4 FY2023, three months to 2023-12-31−$1.18 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-K filed 2024-02-20, accession 0001438533-24-000005.Report this figure(1.76)Basic EPS, Q1 FY2024, three months to 2024-03-31−$1.76 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-01, accession 0001438533-25-000026.Report this figure(0.91)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.91 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-06, accession 0001438533-25-000046.Report this figure(0.70)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.70 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-30, accession 0001438533-25-000056.Report this figurenot reported(0.47)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.47 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-04, accession 0001438533-26-000042.Report this figure(0.14)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-04, accession 0001438533-26-000063.Report this figure0.29Basic EPS, Q3 FY2025, three months to 2025-09-30$0.29 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-10-30, accession 0001438533-25-000056.Report this figurenot reported(0.40)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.40 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-04, accession 0001438533-26-000042.Report this figure(0.37)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.37 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-04, accession 0001438533-26-000063.Report this figure

Balance sheet

Cash and equivalents$117.7m, Q2 FY2026
Shareholders' equity$24.5m, Q2 FY2026
Travere Therapeutics, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m144Cash and equivalents, Q3 FY2023, at 2023-09-30$144.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-07, accession 0001438533-23-000048.Report this figure58.2Cash and equivalents, FY2023, at 2023-12-31$58.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-21, accession 0001438533-25-000010.Report this figure43.3Cash and equivalents, Q1 FY2024, at 2024-03-31$43.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-06, accession 0001438533-24-000020.Report this figure32.3Cash and equivalents, Q2 FY2024, at 2024-06-30$32.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-01, accession 0001438533-24-000031.Report this figure36.4Cash and equivalents, Q3 FY2024, at 2024-09-30$36.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-10-31, accession 0001438533-24-000048.Report this figure58.5Cash and equivalents, FY2024, at 2024-12-31$58.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-19, accession 0001438533-26-000014.Report this figure61.9Cash and equivalents, Q1 FY2025, at 2025-03-31$61.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-01, accession 0001438533-25-000026.Report this figure75.2Cash and equivalents, Q2 FY2025, at 2025-06-30$75.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-06, accession 0001438533-25-000046.Report this figure111Cash and equivalents, Q3 FY2025, at 2025-09-30$110.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-10-30, accession 0001438533-25-000056.Report this figure93.0Cash and equivalents, FY2025, at 2025-12-31$93.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-04, accession 0001438533-26-000063.Report this figure78.4Cash and equivalents, Q1 FY2026, at 2026-03-31$78.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-04, accession 0001438533-26-000042.Report this figure118Cash and equivalents, Q2 FY2026, at 2026-06-30$117.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-04, accession 0001438533-26-000063.Report this figure
Current assets$m686Current assets, Q3 FY2023, at 2023-09-30$686.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-07, accession 0001438533-23-000048.Report this figure617Current assets, FY2023, at 2023-12-31$616.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-21, accession 0001438533-25-000010.Report this figure481Current assets, Q1 FY2024, at 2024-03-31$481.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-06, accession 0001438533-24-000020.Report this figure369Current assets, Q2 FY2024, at 2024-06-30$369.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-01, accession 0001438533-24-000031.Report this figure325Current assets, Q3 FY2024, at 2024-09-30$324.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-10-31, accession 0001438533-24-000048.Report this figure417Current assets, FY2024, at 2024-12-31$416.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-19, accession 0001438533-26-000014.Report this figure374Current assets, Q1 FY2025, at 2025-03-31$374.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-01, accession 0001438533-25-000026.Report this figure380Current assets, Q2 FY2025, at 2025-06-30$379.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-06, accession 0001438533-25-000046.Report this figure371Current assets, Q3 FY2025, at 2025-09-30$371.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-10-30, accession 0001438533-25-000056.Report this figure438Current assets, FY2025, at 2025-12-31$437.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-04, accession 0001438533-26-000063.Report this figure393Current assets, Q1 FY2026, at 2026-03-31$392.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-04, accession 0001438533-26-000042.Report this figure615Current assets, Q2 FY2026, at 2026-06-30$615.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-04, accession 0001438533-26-000063.Report this figure
Total assets$m833Total assets, Q3 FY2023, at 2023-09-30$832.9m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-07, accession 0001438533-23-000048.Report this figure789Total assets, FY2023, at 2023-12-31$788.9m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-21, accession 0001438533-25-000010.Report this figure664Total assets, Q1 FY2024, at 2024-03-31$663.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-06, accession 0001438533-24-000020.Report this figure551Total assets, Q2 FY2024, at 2024-06-30$551.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-01, accession 0001438533-24-000031.Report this figure504Total assets, Q3 FY2024, at 2024-09-30$504.4m. XBRL concept us-gaap:Assets. 10-Q filed 2024-10-31, accession 0001438533-24-000048.Report this figure594Total assets, FY2024, at 2024-12-31$594.1m. XBRL concept us-gaap:Assets. 10-K filed 2026-02-19, accession 0001438533-26-000014.Report this figure549Total assets, Q1 FY2025, at 2025-03-31$548.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-01, accession 0001438533-25-000026.Report this figure555Total assets, Q2 FY2025, at 2025-06-30$555.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-06, accession 0001438533-25-000046.Report this figure539Total assets, Q3 FY2025, at 2025-09-30$538.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-10-30, accession 0001438533-25-000056.Report this figure605Total assets, FY2025, at 2025-12-31$605.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-04, accession 0001438533-26-000063.Report this figure555Total assets, Q1 FY2026, at 2026-03-31$555.2m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-04, accession 0001438533-26-000042.Report this figure799Total assets, Q2 FY2026, at 2026-06-30$799.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-04, accession 0001438533-26-000063.Report this figure
Current liabilities$m139Current liabilities, Q3 FY2023, at 2023-09-30$139.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-07, accession 0001438533-23-000048.Report this figure178Current liabilities, FY2023, at 2023-12-31$177.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-21, accession 0001438533-25-000010.Report this figure173Current liabilities, Q1 FY2024, at 2024-03-31$173.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-06, accession 0001438533-24-000020.Report this figure121Current liabilities, Q2 FY2024, at 2024-06-30$121.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-01, accession 0001438533-24-000031.Report this figure190Current liabilities, Q3 FY2024, at 2024-09-30$190.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-10-31, accession 0001438533-24-000048.Report this figure201Current liabilities, FY2024, at 2024-12-31$200.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-19, accession 0001438533-26-000014.Report this figure182Current liabilities, Q1 FY2025, at 2025-03-31$182.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-01, accession 0001438533-25-000026.Report this figure190Current liabilities, Q2 FY2025, at 2025-06-30$189.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-06, accession 0001438533-25-000046.Report this figure135Current liabilities, Q3 FY2025, at 2025-09-30$135.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-10-30, accession 0001438533-25-000056.Report this figure160Current liabilities, FY2025, at 2025-12-31$159.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-04, accession 0001438533-26-000063.Report this figure125Current liabilities, Q1 FY2026, at 2026-03-31$125.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-04, accession 0001438533-26-000042.Report this figure152Current liabilities, Q2 FY2026, at 2026-06-30$152.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-04, accession 0001438533-26-000063.Report this figure
Total liabilities$m553Total liabilities, Q3 FY2023, at 2023-09-30$553.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-07, accession 0001438533-23-000048.Report this figure588Total liabilities, FY2023, at 2023-12-31$588.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-21, accession 0001438533-25-000010.Report this figure589Total liabilities, Q1 FY2024, at 2024-03-31$589.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-06, accession 0001438533-24-000020.Report this figure536Total liabilities, Q2 FY2024, at 2024-06-30$536.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-01, accession 0001438533-24-000031.Report this figure535Total liabilities, Q3 FY2024, at 2024-09-30$534.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-10-31, accession 0001438533-24-000048.Report this figure535Total liabilities, FY2024, at 2024-12-31$535.0m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-19, accession 0001438533-26-000014.Report this figure516Total liabilities, Q1 FY2025, at 2025-03-31$516.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-01, accession 0001438533-25-000026.Report this figure523Total liabilities, Q2 FY2025, at 2025-06-30$522.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-06, accession 0001438533-25-000046.Report this figure465Total liabilities, Q3 FY2025, at 2025-09-30$465.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-10-30, accession 0001438533-25-000056.Report this figure490Total liabilities, FY2025, at 2025-12-31$490.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-04, accession 0001438533-26-000063.Report this figure456Total liabilities, Q1 FY2026, at 2026-03-31$456.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-04, accession 0001438533-26-000042.Report this figure775Total liabilities, Q2 FY2026, at 2026-06-30$774.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-04, accession 0001438533-26-000063.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m280Shareholders' equity, Q3 FY2023, at 2023-09-30$279.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-10-31, accession 0001438533-24-000048.Report this figure201Shareholders' equity, FY2023, at 2023-12-31$200.8m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-19, accession 0001438533-26-000014.Report this figure74.1Shareholders' equity, Q1 FY2024, at 2024-03-31$74.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-06, accession 0001438533-25-000046.Report this figure15.1Shareholders' equity, Q2 FY2024, at 2024-06-30$15.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0001438533-25-000056.Report this figure(30.5)Shareholders' equity, Q3 FY2024, at 2024-09-30−$30.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0001438533-25-000056.Report this figure59.1Shareholders' equity, FY2024, at 2024-12-31$59.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001438533-26-000063.Report this figure32.8Shareholders' equity, Q1 FY2025, at 2025-03-31$32.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001438533-26-000063.Report this figure32.7Shareholders' equity, Q2 FY2025, at 2025-06-30$32.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001438533-26-000063.Report this figure73.6Shareholders' equity, Q3 FY2025, at 2025-09-30$73.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-10-30, accession 0001438533-25-000056.Report this figure115Shareholders' equity, FY2025, at 2025-12-31$114.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001438533-26-000063.Report this figure98.7Shareholders' equity, Q1 FY2026, at 2026-03-31$98.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001438533-26-000063.Report this figure24.5Shareholders' equity, Q2 FY2026, at 2026-06-30$24.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001438533-26-000063.Report this figure

Cash flow

Operating cash flow$58.1m, Q2 FY2026
Capital expenditure$140.0k, Q3 FY2025
Travere Therapeutics, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(59.1)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$59.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-10-31, accession 0001438533-24-000048. Derived: 9-month figure less the 6-month figure.Report this figure(70.5)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$70.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-19, accession 0001438533-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure(119)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$119.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-01, accession 0001438533-25-000026.Report this figure(40.2)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$40.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-06, accession 0001438533-25-000046. Derived: 6-month figure less the 3-month figure.Report this figure(42.5)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$42.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-30, accession 0001438533-25-000056. Derived: 9-month figure less the 6-month figure.Report this figure(35.7)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$35.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-19, accession 0001438533-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure(42.2)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$42.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-04, accession 0001438533-26-000042.Report this figure5.0Operating cash flow, Q2 FY2025, three months to 2025-06-30$5.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-04, accession 0001438533-26-000063. Derived: 6-month figure less the 3-month figure.Report this figure14.3Operating cash flow, Q3 FY2025, three months to 2025-09-30$14.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-10-30, accession 0001438533-25-000056. Derived: 9-month figure less the 6-month figure.Report this figure60.7Operating cash flow, Q4 FY2025, three months to 2025-12-31$60.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-19, accession 0001438533-26-000014. Derived: 12-month figure less the 9-month figure.Report this figure(40.4)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$40.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-04, accession 0001438533-26-000042.Report this figure58.1Operating cash flow, Q2 FY2026, three months to 2026-06-30$58.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-04, accession 0001438533-26-000063. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$10.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-10-31, accession 0001438533-24-000048. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$25.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-02-20, accession 0001438533-24-000005. Derived: 12-month figure less the 9-month figure.Report this figure0.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-05-06, accession 0001438533-24-000020.Report this figure0.1Capital expenditure, Q2 FY2024, three months to 2024-06-30$82.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-06, accession 0001438533-25-000046. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-30, accession 0001438533-25-000056. Derived: 9-month figure less the 6-month figure.Report this figurenot reportednot reportednot reported0.1Capital expenditure, Q3 FY2025, three months to 2025-09-30$140.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-10-30, accession 0001438533-25-000056. Derived: 9-month figure less the 6-month figure.Report this figurenot reportednot reportednot reported
Share repurchases$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported

Shares

Diluted shares (weighted)93.48m, Q2 FY2026
Travere Therapeutics, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares64.0Diluted shares (weighted), Q3 FY2022, three months to 2022-09-3064,033,759 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-07, accession 0001438533-23-000048.Report this figure68.2Diluted shares (weighted), Q1 FY2023, three months to 2023-03-3168,174,099 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-06, accession 0001438533-24-000020.Report this figure76.0Diluted shares (weighted), Q2 FY2023, three months to 2023-06-3076,001,801 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-01, accession 0001438533-24-000031.Report this figure76.3Diluted shares (weighted), Q3 FY2023, three months to 2023-09-3076,305,603 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-10-31, accession 0001438533-24-000048.Report this figure77.1Diluted shares (weighted), Q1 FY2024, three months to 2024-03-3177,136,493 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-01, accession 0001438533-25-000026.Report this figure77.5Diluted shares (weighted), Q2 FY2024, three months to 2024-06-3077,500,245 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-06, accession 0001438533-25-000046.Report this figure77.8Diluted shares (weighted), Q3 FY2024, three months to 2024-09-3077,779,379 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-30, accession 0001438533-25-000056.Report this figure88.4Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3188,355,973 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-04, accession 0001438533-26-000042.Report this figure88.9Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3088,945,624 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-04, accession 0001438533-26-000063.Report this figure103Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30102,618,560 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-10-30, accession 0001438533-25-000056.Report this figure91.9Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3191,868,862 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-04, accession 0001438533-26-000042.Report this figure93.5Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3093,479,416 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-04, accession 0001438533-26-000063.Report this figure

Shares outstanding: 94.26mShares outstanding, period not labelled, at 2026-07-3094,261,082 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-04, accession 0001438533-26-000063.Report this figure at Jul 30, 2026, from the cover of the 10-Q filed Aug 4, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. Listed shows no prices and gives no investment advice.